CASI Pharmaceuticals CASIF
OTC CASIF
$0.12 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

CASI Pharmaceuticals (CASIF) Return on Capital Employed [ROCE] (2023 - 2025)

Updated

CASI Pharmaceuticals (CASIF) reported Return on Capital Employed [ROCE] of -299.58% for Q1 2025.

Analysis

CASI Pharmaceuticals (CASIF) Return on Capital Employed [ROCE] (2023 - 2025) Analysis & Trends

For FY2022, CASI Pharmaceuticals posted Return on Capital Employed [ROCE] of -33.94%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 CASI Pharmaceuticals 2.47 Mn -18.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -299.58%
Jun 30, 2024 -59.40%
Sep 30, 2023 -57.02%
Jun 30, 2023 -52.29%
Mar 31, 2023 -43.80%
API Access

CASI Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CASIF&period=max&api_key=YOUR_API_KEY